|
Irvine, CA - February 8, 2006
DataLabs to Integrate Galt's dsNavigator Coding Product with Their Hybrid Clinical Data
DataLabs, an innovative developer of Web-based software applications for clinical development, today announced a partnership with Galt Associates, an international leader in managing risk through information, to integrate Galt's dsNavigator coding and dictionary management product with DataLabs eCDM platform. The result is a single integrated solution that combines the robust features of two best-of-breed software applications.
"Customers are looking for sophisticated coding solutions to complement their clinical data management operations," said Nick Richards, COO of DataLabs. "We considered all of the offerings in the marketplace and found Galt's product to be the best fit for our growing number of customers who demand robust features and a low total cost of ownership. We are excited about our partnership with Galt and look forward to working together to bring new innovative products to market."
DataLabs Clinical, a single data management system that unifies the functionality of paper data entry (PDE) with the flexibility of electronic data capture (EDC), is an electronic clinical data management platform that enables the biopharmaceutical and contract research organizations (CRO) industries to streamline clinical data management processes and reduce the time and costs associated with clinical trials. Galt's dsNavigator is a trusted and proven Web-based solution that offers rapid and accurate coding of adverse event and drug verbatims throughout each phase of clinical research. Featuring a configurable and easy-to-use interface, it provides a single solution for dictionary management, searching, browsing and batch or interactive coding. dsNavigator allows all parties involved to effectively assign, review and communicate coding decisions regardless of differences in terminology, dictionary versions, training levels or regulatory requirements at any time during the trial. Coupled with DataLabs Clinical, this intelligent coding and dictionary management solution saves customers time and resources.
"Galt is extremely pleased to enter into this dynamic new partnership," said Y. Renee Lewis, CEO of Galt Associates. "Datalabs thoroughly understands the importance of the quality and consistency of the data collected. By integrating Galt's products, Datalabs is able to deliver comprehensive efficient solutions to meet the variety of needs of their clients."
About DataLabs
DataLabs is an innovative developer of Web-based applications for clinical development that helps the CRO and biopharmaceutical industries accelerate clinical trials with proven software for eClinical Data Management, eCollaboration, and eLearning. Based on Microsoft platform technology, XML Web services and CDISC ODM standards, the DataLabs eClinical Solution product suite adapts to established operating procedures and integrates easily with existing technology systems. As a result, DataLabs' customers enjoy a low total cost of ownership and high return on investment. Major pharmaceutical companies, government entities, healthcare organizations and contract research organizations (CROs) are currently realizing time and cost savings using DataLabs eClinical Solutions DataLabs, a Microsoft Certified Partner, is based in Irvine, Calif. with East Coast offices in Pennsylvania. For more information, please visit www.datalabs.com.
About Galt Associates
With over a decade of experience, Galt is an international leader in helping clients manage risk through information. Galt's evidence-based solutions integrate the recognized expertise of its medical and scientific personnel with innovative technologies to ensure timely answers to clients' critical questions. This integrated approach allows Galt to deliver medical risk management and communication strategies that address the benefits and risks associated with the full range of medical therapies and interventions. Galt supports over 70 pharmaceutical, medical device, and biotechnology companies, as well as CROs and research institutions located throughout the US and Europe.
|
